Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0349 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0032 | 0.0219 | 0.0213 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0349 | 0.0344 |
Loa Loa (eye worm) | thymidylate synthase | 0.0347 | 0.8312 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0349 | 0.0419 |
Echinococcus granulosus | tumor protein p63 | 0.0341 | 0.8142 | 0.9793 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0032 | 0.0219 | 0.0213 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0065 | 0.0022 |
Mycobacterium ulcerans | thymidylate synthase | 0.0347 | 0.8312 | 1 |
Brugia malayi | dihydrofolate reductase family protein | 0.0172 | 0.3804 | 0.4548 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.0172 | 0.3804 | 0.0362 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0413 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0165 | 0.3635 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0341 | 0.8142 | 0.9793 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0219 | 0.0263 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0026 | 0.0065 | 0.0022 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0347 | 0.8312 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0349 | 0.0344 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0102 | 0.2009 | 0.2378 |
Brugia malayi | Dihydrofolate reductase | 0.0172 | 0.3804 | 0.4548 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0172 | 0.3804 | 0.4534 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0172 | 0.3804 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0219 | 0.0187 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0219 | 0.0263 |
Plasmodium falciparum | flap endonuclease 1 | 0.0026 | 0.0065 | 0.0022 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0026 | 0.0065 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0347 | 0.8312 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0219 | 0.0187 |
Echinococcus granulosus | dihydrofolate reductase | 0.0172 | 0.3804 | 0.4534 |
Echinococcus multilocularis | GPCR, family 2 | 0.0032 | 0.0219 | 0.0187 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0671 | 0.076 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0219 | 0.0263 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0219 | 0.0213 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0347 | 0.8312 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0413 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.007 | 0.1181 | 0.1375 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0102 | 0.2009 | 0.2378 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0032 | 0.0219 | 0.0213 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0065 | 0.0022 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0349 | 1 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0026 | 0.0065 | 0.0026 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.2482 | 0.295 |
Echinococcus multilocularis | thymidylate synthase | 0.0347 | 0.8312 | 1 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0349 | 0.0369 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1181 | 0.1375 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.2009 | 0.2378 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0413 | 1 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.005 | 0.0671 | 0.0808 |
Echinococcus granulosus | GPCR family 2 | 0.0032 | 0.0219 | 0.0187 |
Onchocerca volvulus | 0.0347 | 0.8312 | 1 | |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0413 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.2482 | 0.295 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0413 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.1181 | 0.142 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0026 | 0.0065 | 0.0022 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0165 | 0.3635 | 0.3607 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0219 | 0.0187 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0349 | 0.0419 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0349 | 1 |
Schistosoma mansoni | dihydrofolate reductase | 0.0172 | 0.3804 | 0.4576 |
Echinococcus granulosus | thymidylate synthase | 0.0347 | 0.8312 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0219 | 0.0187 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0102 | 0.2009 | 0.2378 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0172 | 0.3804 | 0.4548 |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.2482 | 0.295 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0065 | 0.0022 |
Brugia malayi | Flap endonuclease-1 | 0.0026 | 0.0065 | 0.0026 |
Brugia malayi | thymidylate synthase | 0.0347 | 0.8312 | 1 |
Brugia malayi | hypothetical protein | 0.0165 | 0.3635 | 0.4343 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0349 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0219 | 0.0263 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.